Cellbyte vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-10-09
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionCellbyteIsomorphic Labs
Primary FocusMarket access & pricing intelligence for drug launchesAI-driven drug discovery & molecular design
Key FeatureDrug Explorer, Document Intelligence, Agentic WorkflowsAlphaFold-based Drug Design Engine, generative & predictive AI
Target UsersPricing & market access teams in pharmaPharma R&D teams, large-scale drug development programs
IntegrationEMA, FDA, HAS, G-BA, SharePoint, OneDrive, Google WorkspaceNot disclosed (proprietary models, pharma partnerships)
Best ForShortening P&MA research from weeks to days for launch planningAccelerating lead optimization & novel molecule design

Cellbyte and Isomorphic Labs serve completely different pharmaceutical value chain stages. Cellbyte is ideal for launch-focused P&MA teams needing rapid regulatory/HTA intelligence and agentic workflows, while Isomorphic Labs is for preclinical R&D groups seeking deep AI-driven drug design partnerships. Choose Cellbyte if your bottleneck is market access speed; choose Isomorphic Labs if you need predictive molecule modeling at scale (and have multi-million-dollar budgets).

Cellbyte
Cellbyte

Cellbyte is an AI workspace for pharmaceutical Pricing & Market Access teams, turning HTA and pricing research from weeks into minutes.

Visit Website
Isomorphic Labs
Isomorphic Labs

Isomorphic Labs applies generative AI drug discovery to design novel molecules and predict how candidates will perform.

Visit Website
Pricing
Contact Sales
Contact Sales
Plans
—
—
Popularity
8 views
7.5k views
Skill Level
Intermediate
Advanced
API Available
Platforms
Web
—
Categories
🧬 Drug Discovery & Life Sciences📊 Data & Analytics
🧬 Drug Discovery & Life Sciences
Features
Drug Explorer: structured global regulatory, HTA, access, and pricing data from 100+ sources
Document Intelligence: extract insights from lengthy, multilingual filings
Agentic Workflows: human-in-the-loop agents for recurring research tasks
Data Vault: upload proprietary data for secure benchmarking and internal sharing
Opportunity assessment: disease landscaping across regulatory, HTA, and pricing signals
HTA and pricing research: map HTA outcomes to historical and current prices across markets
Competitive intelligence: track approvals, launches, policy shifts, and price signals
Outcomes validation: link internal evidence to external payer data
Source-attributed answers linking every insight to the originating passage
Plain-language research interface on a proprietary clinical, regulatory, HTA, and pricing database
Collaborative workspace with team-based access control and knowledge sharing
Expert-led services arm delivering evidence reviews, analysis, and sourced recommendations
GDPR compliant, with the technical team based in Germany
ISO/IEC 27001:2022 certified information security management
SOC 2 Type II audit in progress
Drug Design Engine spanning generative molecule design through lead optimization
Predictive AI models that anticipate how candidate drugs will perform
Generative models for designing novel molecules
Builds on and beyond the Nobel-winning AlphaFold system
End-to-end research collaborations from target identification to lead optimization
Digital biology approach aimed at discovery at digital speed
Named pharma partners include Johnson & Johnson, Novartis and Eli Lilly
Joined the Virtual Biology Initiative to build foundational data for AI disease models
Funder of Biohub's $1.8B initiative to train AI models that predict cell behavior
Bioresilience framework for biological threats and health emergencies
Series B investment round announced May 2026 to scale the Drug Design Engine
Follows a $600M external raise in March 2025
President Max Jaderberg appointed November 2025 to integrate AI and science
Interdisciplinary team of drug discovery experts and ML specialists
Founded by Demis Hassabis, who serves as CEO
Integrations
Microsoft SharePoint
Microsoft OneDrive
Google Workspace
Microsoft Word

Who should pick which

  • Pricing & Market Access Manager at a mid-size pharma
    Pick: Cellbyte

    Cellbyte directly automates HTA and pricing research, aggregating data from 100+ sources including EMA, HAS, and G-BA into a collaborative workspace. It cuts weeks of manual document analysis, exactly what a P&MA team needs for launch planning.

  • Chief Scientific Officer at a large pharma with drug discovery pipeline
    Pick: Isomorphic Labs

    Isomorphic Labs' predictive and generative AI models (AlphaFold) enable rapid lead optimization and novel molecule design. Its partnership model fits large-scale programs, as shown by J&J and Novartis collaborations.

  • HEOR Analyst needing rapid competitive intelligence
    Pick: Cellbyte

    Cellbyte's Competitive Intelligence tracking and source-attributed answers provide near real-time policy shifts and price signals, essential for health economics modeling before launch.

  • Head of R&D at a biotech seeking early-stage AI drug design tools
    Pick: Isomorphic Labs

    Isomorphic Labs' Drug Design Engine, combined with its world-class ML team, offers digital biology simulation at scale — ideal for projects needing advanced protein-ligand interaction modeling.

Frequently Asked Questions

Cellbyte vs Isomorphic Labs: which should you choose?

Cellbyte and Isomorphic Labs serve completely different pharmaceutical value chain stages. Cellbyte is ideal for launch-focused P&MA teams needing rapid regulatory/HTA intelligence and agentic workflows, while Isomorphic Labs is for preclinical R&D groups seeking deep AI-driven drug design partnerships. Choose Cellbyte if your bottleneck is market access speed; choose Isomorphic Labs if you need predictive molecule modeling at scale (and have multi-million-dollar budgets).

Do Cellbyte and Isomorphic Labs compete?

No. Cellbyte targets post-discovery market access intelligence; Isomorphic Labs focuses on pre-clinical drug discovery. They are complementary for pharma companies.

Can I use Isomorphic Labs as a standalone software?

No. Isomorphic Labs operates only through deep pharma partnerships, not as a SaaS product. You need a collaboration agreement.

Does Cellbyte integrate with Isomorphic Labs?

No integration is disclosed. But a pharma company could use Cellbyte for launch planning of a drug discovered via Isomorphic Labs.

Which tool is more affordable?

Cellbyte is likely less expensive (enterprise SaaS for a team), while Isomorphic Labs requires multi-million-dollar partnership commitments.

Is Cellbyte suitable for early-stage drug discovery?

No. Cellbyte is designed for Pricing & Market Access, not for molecular design or preclinical research.

Does Isomorphic Labs provide regulatory or HTA data?

No. Its focus is predictive modeling for drug design, not market access intelligence.

More Cellbyte or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026